CGS-15943 inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets adenosine A1 receptor, adenosine A2A receptor, adenosine A2B receptor, adenosine A3 receptor, p110δ, and p110γ.
CGS-15943 can be used for research on the role of adenosine receptors in various physiological and pathological processes in the central nervous system.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
